• 1247 Citations
  • 20 h-Index
19972017
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

Sirolimus Medicine & Life Sciences
Breast Neoplasms Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Triple Negative Breast Neoplasms Medicine & Life Sciences
Phosphatidylinositol 3-Kinases Medicine & Life Sciences
Heterografts Medicine & Life Sciences
Paclitaxel Medicine & Life Sciences
Stearoyl-CoA Desaturase Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1997 2017

5 Citations

A population of heterogeneous breast cancer patient-derived xenografts demonstrate broad activity of PARP inhibitor in BRCA1/2 wild-type tumors

Evans, K. W., Yuca, E., Akcakanat, A., Scott, S. M., Arango, N. P., Zheng, X., Chen, K., Tapia, C., Tarco, E., Eterovic, A. K., Black, D. M., Litton, J. K., Yap, T. A., Tripathy, D., Mills, G. B. & Meric-Bernstam, F., Nov 1 2017, In : Clinical Cancer Research. 23, 21, p. 6468-6477 10 p.

Research output: Contribution to journalArticle

Triple Negative Breast Neoplasms
Heterografts
Breast Neoplasms
Protein Array Analysis
Phosphatidylinositol 3-Kinases
1 Citations

Selinexor (KPT-330) demonstrates anti-tumor efficacy in preclinical models of triple-negative breast cancer

Arango, N. P., Yuca, E., Zhao, M., Evans, K. W., Scott, S., Kim, C., Gonzalez-Angulo, A. M., Janku, F., Ueno, N. T., Tripathy, D., Akcakanat, A., Naing, A. & Meric-Bernstam, F., Aug 15 2017, In : Breast Cancer Research. 19, 1, 93.

Research output: Contribution to journalArticle

Triple Negative Breast Neoplasms
eribulin
Neoplasms
Cell Line
Inhibitory Concentration 50
1 Citations

Erratum: Ability to generate patient-derived breast cancer xenografts is enhanced in chemoresistant disease and predicts poor patient outcomes (PLoS ONE (2015) 10:9 (e0136851) DOI: 10.1371/journal.pone.0136851)

McAuliffe, P. F., Evans, K. W., Akcakanat, A., Chen, K., Zheng, X., Zhao, H., Eterovic, A. K. B., Sangai, T., Holder, A. M., Sharma, C., Chen, H., Do, K-A., Tarco, E., Gagea Iurascu, M., Naff, K. A., Sahin, A. A., Multani, A. S., Black, D. M., Mittendorf, E. A., Bedrosian, I. & 3 othersMills, G. B., Gonzalez-Angulo, A. M. & Meric-Bernstam, F., Mar 1 2016, In : PloS one. 11, 3, e0151121.

Research output: Contribution to journalComment/debate

Heterografts
breast neoplasms
Breast Neoplasms

Modeling breast cancer heterogeneity with patient-derived xenografts

Evans, K. W., Paez-Arango, N., Akcakanat, A., Yuca, E. & Meric-Bernstam, F., Oct 25 2016, Patient Derived Tumor Xenograft Models: Promise, Potential and Practice. Elsevier Inc., p. 243-256 14 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

Heterografts
Breast Neoplasms
Genetic Drift
Neoplasms
Transplants
14 Citations

Ability to generate patient-derived Breast cancer xenografts is enhanced in chemoresistant disease and predicts poor patient outcomes

McAuliffe, P. F., Evans, K. W., Akcakanat, A., Chen, K., Zheng, X., Zhao, H., Eterovic, A. K. B., Sangai, T., Holder, A. M., Sharma, C., Chen, H., Do, K-A., Tarco, E., Gagea Iurascu, M., Naff, K. A., Sahin, A. A., Multani, A. S., Black, D. M., Mittendorf, E. A., Bedrosian, I. & 3 othersMills, G. B., Gonzalez-Angulo, A. M. & Meric-Bernstam, F., Sep 1 2015, In : PloS one. 10, 9, e0136851.

Research output: Contribution to journalArticle

Heterografts
breast neoplasms
Chemotherapy
Breast Neoplasms
Tumors